Skip to main content

Table 1 Demographic characteristics and primary antipsychotic treatment

From: A double-blind randomized study assessing safety and efficacy following one-year adjunctive treatment with bitopertin, a glycine reuptake inhibitor, in Japanese patients with schizophrenia

Characteristics 5 mg (n = 15) 10 mg (n = 73) 20 mg (n = 73)
Demographics
 Male, n (%) 12 (80) 51 (70) 47 (64)
 Age in years, mean (SD) 41.8 (11.9) 39.9 (12.2) 41.8 (13.8)
 BMI (kg/m2), mean (SD) 27.0 (4.9) 26.0 (4.2) 25.4 (4.9)
Schizophrenia type, n (%)
 Paranoid 11 (73) 43 (59) 38 (52)
 Disorganized 1 (7) 11 (15) 10 (14)
 Catatonic - 2 (3) -
 Undifferentiated - 10 (14) 7 (10)
 Residual 3 (20) 7 (10) 18 (25)
Previous antipsychotics frequently used, n (%)
 Risperidone 4 (27) 8 (11) 12 (16)
 Aripiprazole 2 (13) 6 (8) 13 (18)
 Olanzapine 1 (7) 7 (10) 9 (12)
Primary antipsychotic treatment
 Type of Antipsychotics, n (%)    
  Atypical 14 (93) 67 (92) 68 (93)
  Typical 1 (7) 6 (8) 5 (7)
 Route, n (%)
  P.O. 11 (73) 69 (95) 67 (92)
  Infusion 4 (27) 4 (5) 6 (8)
 Primary Antipsychotics, n (%)
  Risperidone 4 (27) 18 (25) 17 (23)
  Olanzapine 5 (33) 19 (26) 15 (21)
  Aripiprazole 2 (13) 16 (22) 20 (27)
  Paliperidone 1 (7) 4 (5) 9 (12)
  Others 3 (20) 16 (22) 12 (16)
  1. Abbreviations: SD standard deviation